Philanthropic Leadership Enables Trailblazing Alzheimer’s Research
Philanthropic Leadership Enables Trailblazing Alzheimer’s Research
The Dolby family has supported Gladstone research since 2015
Donor Stories Alzheimer’s Disease436 - 450 of 1220 Results Clear All
The Dolby family has supported Gladstone research since 2015
Donor Stories Alzheimer’s DiseaseSan Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.
Gladstone Experts COVID-19 Virology Greene Lababc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.
Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCsScience is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts COVID-19 Virology Ott LabBenoit Bruneau and Katie Pollard study DNA folding to identify the genetic causes of congenital heart disease
Grants News Release Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard LabThe 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders
Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lababc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts COVID-19 Cardiovascular Disease Srivastava LabLearn how a Gladstone bioinformatician is spending his days during shelter-in-place
Profile Bioinformatics Core Finkbeiner LabJim Allison spoke along side a panel of experts in cancer immunotherapy.
Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Graduate Students and PostdocsPOZ—Finding a cure to HIV will require a full understanding of the latent reservoir, the population of cells in which the virus hides, evading antiretroviral therapy. Gladstone scientist Nadia Roan describes her recent work mapping an atlas of the reservoir, and how it provides hope that new therapies could be developed to target and eliminate reservoir cells.
Gladstone Experts HIV/AIDS Virology Roan LabGladstone celebrates inspiring women in STEM
Womens Initiative DiversityIn honor of Ada Lovelace Day, Katie Pollard discusses what it’s like to be a woman in STEM and how being an outsider has helped shape her career.
Mentoring Task Force Womens Initiative Profile Data Science and Biotechnology Pollard Lab Big Data DiversityThe New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.
Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava LabA new series led by Gladstone, Georgia Tech, the Molecular Engineering & Sciences Institute at University of Washington, and UT Austin starts a national conversation about race and diversity in STEM fields.
Communications Elevated Voices DiversityDoudna’s discovery of the CRISPR-Cas9 system revolutionized biomedical research
Awards News Release Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene Editing